A 2026 review summarizes recurrent molecular alterations, immune suppression, multimodal imaging and current treatment strategies for primary cardiac angiosarcoma, a...

A 124-patient randomized trial will test whether probiotics reduce side effects and affect outcomes in advanced or recurrent ovarian cancer,...

In a two-center observational cohort of 120 patients with advanced NSCLC and COPD, higher serum IL-6 measured after six treatment...

A 23-article collection reports advances in kidney cancer classification, prognosis and treatment while showing that prevention, early detection and prospective...

A Swedish nationwide cohort study associated breast-conserving surgery followed by radiotherapy with favorable overall survival in ductal carcinoma in situ,...

A focused review finds that antibody–drug conjugates directly kill breast-cancer cells, while evidence that they remodel human tumor immunity remains...

A study combining clinical-data analysis, functional cell experiments and single-cell transcriptomics linked the METTL1–NSUN1 axis to malignant progression and immune-microenvironment...

A preclinical study found that fucoidan-coated zein nanoparticles increased psoralen uptake in 4T1 breast-cancer cells, prolonged tumor-associated retention in mice,...

A CD276-targeted antibody-drug conjugate combined with mitochondrial-disrupting gene therapy outperformed either treatment alone in two preclinical models of metastatic triple-negative...

A prospective single-center cohort linked baseline thyroid autoantibodies and higher TSH to more immune-related thyroid dysfunction during advanced lung cancer...